ATE195626T1 - Taxol enthaltende zusammensetzung zur verwendung in der organkonservierung und als kardioplegisches mittel - Google Patents

Taxol enthaltende zusammensetzung zur verwendung in der organkonservierung und als kardioplegisches mittel

Info

Publication number: ATE195626T1
Authority: AT; Austria
Prior art keywords: composition containing; organ preservation; containing taxol; cardioplegic agent; taxol
Prior art date: 1996-05-07

Application number

AT97303064T

Other languages

English (en)

Inventor

James H Southard

Original Assignee

Wisconsin Alumni Res Found

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-05-07

Filing date

1997-05-06

Publication date

2000-09-15

1997-05-06 Application filed by Wisconsin Alumni Res Found filed Critical Wisconsin Alumni Res Found

2000-09-15 Application granted granted Critical

2000-09-15 Publication of ATE195626T1 publication Critical patent/ATE195626T1/de

Links

229930012538 Paclitaxel Natural products 0.000 title abstract 2
229960001592 paclitaxel Drugs 0.000 title abstract 2
RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 title abstract 2
239000000372 cardioplegic agent Substances 0.000 title 1
239000000082 organ preservation Substances 0.000 title 1
238000002513 implantation Methods 0.000 abstract 2
210000000056 organ Anatomy 0.000 abstract 1
230000010412 perfusion Effects 0.000 abstract 1
238000004321 preservation Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/10—Preservation of living parts
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/10—Preservation of living parts
- A01N1/12—Chemical aspects of preservation
- A01N1/122—Preservation or perfusion media
- A01N1/125—Freeze protecting agents, e.g. cryoprotectants or osmolarity regulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Dentistry (AREA)
Wood Science & Technology (AREA)
Environmental Sciences (AREA)
Zoology (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Epoxy Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AT97303064T 1996-05-07 1997-05-06 Taxol enthaltende zusammensetzung zur verwendung in der organkonservierung und als kardioplegisches mittel ATE195626T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US08/646,055 US5696152A (en)	1996-05-07	1996-05-07	Taxol composition for use as organ preservation and cardioplegic agents

Publications (1)

Publication Number	Publication Date
ATE195626T1 true ATE195626T1 (de)	2000-09-15

Family

ID=24591558

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT97303064T ATE195626T1 (de)	1996-05-07	1997-05-06	Taxol enthaltende zusammensetzung zur verwendung in der organkonservierung und als kardioplegisches mittel

Country Status (5)

Country	Link
US (1)	US5696152A (de)
EP (1)	EP0806140B1 (de)
JP (1)	JP3969785B2 (de)
AT (1)	ATE195626T1 (de)
DE (1)	DE69702880T2 (de)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6680305B1 (en) *	1993-06-04	2004-01-20	Biotime, Inc.	Physiologically acceptable aqueous solutions and methods for their use
US6303355B1 (en)	1999-03-22	2001-10-16	Duke University	Method of culturing, cryopreserving and encapsulating pancreatic islet cells
US6365385B1 (en)	1999-03-22	2002-04-02	Duke University	Methods of culturing and encapsulating pancreatic islet cells
FR2793651B1 (fr) *	1999-05-18	2003-05-16	Cair L G L	Solution aqueuse de conservation de tissus et d'organes
DE10020507A1 (de) *	2000-04-26	2001-11-08	Wolfgang Thasler	Lösung zur Konservierung menschlicher Leberzellen, konservierte menschliche Leberzelle, ihre Herstellung und Verwendung
WO2002009738A1 (en)	2000-07-28	2002-02-07	Murphy Christopher J	Transplant media
GB0028414D0 (en)	2000-11-22	2001-01-03	Univ Leeds	Flush preservation solution
DE10209821A1 (de)	2002-03-06	2003-09-25	Biotechnologie Ges Mittelhesse	Kopplung von Proteinen an ein modifiziertes Polysaccharid
DE10209822A1 (de) *	2002-03-06	2003-09-25	Biotechnologie Ges Mittelhesse	Kopplung niedermolekularer Substanzen an ein modifiziertes Polysaccharid
MXPA05002594A (es)	2002-09-11	2005-05-27	Fresenius Kabi Gmbh	Derivados de polipeptidos con hidroxialquilalmidon, especialmente derivados de eritropoyetina con hidroxialquilalmidon.
EP1475434A1 (de)	2003-05-09	2004-11-10	Oncoscience AG	Verfahren zur Lagerung von Tumorzellen
US20050059638A1 (en) *	2003-08-04	2005-03-17	Kelly Michael G.	Aryl, heteroaromatic and bicyclic aryl nitrone compounds, prodrugs and pharmaceutical compositions of the same to treat human disorders
WO2005014655A2 (en)	2003-08-08	2005-02-17	Fresenius Kabi Deutschland Gmbh	Conjugates of hydroxyalkyl starch and a protein
US20050182060A1 (en) *	2004-02-13	2005-08-18	Kelly Michael G.	2-Substituted and 4-substituted aryl nitrone compounds
EP2336192A1 (de)	2004-03-11	2011-06-22	Fresenius Kabi Deutschland GmbH	Hydroxyalkylstärke-Protein-Konjugate, durch reduktive Aminierung hergestellt.
JP2008506750A (ja) *	2004-07-22	2008-03-06	ティオマトリックス・フォルシュンクス・ウント・べラートゥンクス・ゲーエムベーハー	チオール基を含む化合物の排出ポンプ抑制剤としての使用
US20080161423A1 (en) *	2005-03-04	2008-07-03	Atsushi Kudo	Organ Function Maintaining or Amelorating Solution
WO2006093314A1 (ja) *	2005-03-04	2006-09-08	National University Corporation, Tokyo Medical And Dental University	臓器機能維持改善液
GB0612877D0 (en) *	2006-06-29	2006-08-09	Univ Edinburgh	Organ preservation solution
EP2070950A1 (de)	2007-12-14	2009-06-17	Fresenius Kabi Deutschland GmbH	Hydroxyalkylstärkederivate und deren Herstellungsverfahren
US12279610B2 (en)	2011-03-15	2025-04-22	Paragonix Technonogies, Inc.	System for hypothermic transport of samples
US9867368B2 (en)	2011-03-15	2018-01-16	Paragonix Technologies, Inc.	System for hypothermic transport of samples
US11178866B2 (en)	2011-03-15	2021-11-23	Paragonix Technologies, Inc.	System for hypothermic transport of samples
US9253976B2 (en)	2011-03-15	2016-02-09	Paragonix Technologies, Inc.	Methods and devices for preserving tissues
US8835158B2 (en)	2011-03-15	2014-09-16	Paragonix Technologics, Inc.	Apparatus for oxygenation and perfusion of tissue for organ preservation
US9426979B2 (en)	2011-03-15	2016-08-30	Paragonix Technologies, Inc.	Apparatus for oxygenation and perfusion of tissue for organ preservation
US8828710B2 (en)	2011-03-15	2014-09-09	Paragonix Technologies, Inc.	System for hypothermic transport of samples
US12096765B1 (en)	2011-03-15	2024-09-24	Paragonix Technologies, Inc.	System for hypothermic transport of samples
US9560846B2 (en)	2012-08-10	2017-02-07	Paragonix Technologies, Inc.	System for hypothermic transport of biological samples
US8785116B2 (en)	2012-08-10	2014-07-22	Paragonix Technologies, Inc.	Methods for evaluating the suitability of an organ for transplant
US10440947B2 (en)	2013-11-15	2019-10-15	Inserm (Institut National De La Sante Et De La Recherche Medicale)	Aqueous solution for preserving an organ and uses during hypothermic ischemia
US20210400952A1 (en)	2017-06-07	2021-12-30	Paragonix Technologies, Inc.	Apparatus for tissue transport and preservation
CA3066625A1 (en)	2017-06-07	2018-12-13	Paragonix Technologies, Inc.	Apparatus for tissue transport and preservation
WO2020252148A1 (en)	2019-06-11	2020-12-17	Paragonix Technologies, Inc.	Organ transport container with antiviral therapy
US11632951B2 (en)	2020-01-31	2023-04-25	Paragonix Technologies, Inc.	Apparatus for tissue transport and preservation
EP4583707A1 (de)	2022-09-08	2025-07-16	Paragonix Technologies, Inc.	Hypothermische gewebelagerung
USD1031028S1 (en)	2022-09-08	2024-06-11	Paragonix Technologies, Inc.	Tissue suspension adaptor
US12357533B2 (en)	2023-08-25	2025-07-15	Paragonix Technologies, Inc.	Systems and methods for maintaining organ pressure
US12410408B2 (en)	2024-02-02	2025-09-09	Paragonix Technologies, Inc.	Method for hypothermic transport of biological samples
US20250311718A1 (en)	2024-04-09	2025-10-09	Paragonix Technologies, Inc.	Systems and methods for preservation of an organ
USD1087382S1 (en)	2025-01-30	2025-08-05	Paragonix Technologies, Inc.	Device for transporting a biological sample

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4879283A (en) *	1985-10-03	1989-11-07	Wisconsin Alumni Research Foundation	Solution for the preservation of organs
US4798824A (en) *	1985-10-03	1989-01-17	Wisconsin Alumni Research Foundation	Perfusate for the preservation of organs
WO1991009520A1 (en) *	1989-12-21	1991-07-11	The Regents Of The University Of California	Novel and improved technology for preservation of organs for transplantation
US5145771A (en) *	1990-04-12	1992-09-08	The University Of North Carolina At Chapel Hill	Rinse solution for organs and tissues
US5407683A (en) *	1990-06-01	1995-04-18	Research Corporation Technologies, Inc.	Pharmaceutical solutions and emulsions containing taxol
US5059699A (en) *	1990-08-28	1991-10-22	Virginia Tech Intellectual Properties, Inc.	Water soluble derivatives of taxol
US5407793A (en) *	1991-10-18	1995-04-18	University Of Pittsburgh Of The Commonwealth System Of Higher Education	An aqueous heart preservation and cardioplegia solution
US5344775A (en) *	1991-11-15	1994-09-06	Escagenetics Corporation	Synthesis of taxanes in culture using pseudocalluscells
US5451392A (en) *	1992-03-03	1995-09-19	The Research And Development Institute At Montana State University	Production of taxol
ATE194767T1 (de) *	1992-03-23	2000-08-15	Univ Georgetown	In liposomen verkapseltes taxol und verwendungsverfahren
US5370989A (en) *	1992-04-03	1994-12-06	The Trustees Of Columbia University In The City Of New York	Solution for prolonged organ preservation
AU664074B2 (en) *	1992-06-26	1995-11-02	Torii Pharmaceutical Co., Ltd.	Organ preserving fluid
WO1994005282A1 (en) *	1992-09-04	1994-03-17	The Scripps Research Institute	Water soluble taxol derivatives
AU5735094A (en) *	1992-12-02	1994-06-22	Thomas Jefferson University	Methods of killing protozoal parasites
US5405742A (en) *	1993-07-16	1995-04-11	Cyromedical Sciences, Inc.	Solutions for tissue preservation and bloodless surgery and methods using same
AU7560994A (en) *	1993-08-12	1995-03-14	University Of North Carolina At Chapel Hill, The	Rinse solution for organs and tissues
IL127598A (en) *	1994-01-28	2003-04-10	Upjohn Co	Process for preparing isotaxol analogs
US5428039A (en) *	1994-02-20	1995-06-27	The Center For Innovative Technology	Method for electively achieving reversible hyperpolarized cardiac arrest

1996
- 1996-05-07 US US08/646,055 patent/US5696152A/en not_active Expired - Fee Related
1997
- 1997-05-02 JP JP11472497A patent/JP3969785B2/ja not_active Expired - Fee Related
- 1997-05-06 EP EP97303064A patent/EP0806140B1/de not_active Expired - Lifetime
- 1997-05-06 AT AT97303064T patent/ATE195626T1/de not_active IP Right Cessation
- 1997-05-06 DE DE69702880T patent/DE69702880T2/de not_active Expired - Fee Related

Also Published As

Publication number	Publication date
JPH1045502A (ja)	1998-02-17
DE69702880T2 (de)	2001-03-01
EP0806140B1 (de)	2000-08-23
JP3969785B2 (ja)	2007-09-05
EP0806140A1 (de)	1997-11-12
DE69702880D1 (de)	2000-09-28
US5696152A (en)	1997-12-09

Legal Events

Date	Code	Title	Description
2001-01-15	UEP	Publication of translation of european patent specification
2004-02-15	REN	Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
DE69702880D1 (de)	2000-09-28	Taxol enthaltende Zusammensetzung zur Verwendung in der Organkonservierung und als kardioplegisches Mittel
ATE205391T1 (de)	2001-09-15	Nimesulid zur aüsserlichen anwendung
DE69402330D1 (de)	1997-04-30	Analgetisches mittel und dessen verwendung
ATE248614T1 (de)	2003-09-15	Gewebeklebstoff auf der basis von fibrinogen und verwendung desselben zur herstellung eines hämostyptikum
ES2072452T3 (es)	1995-07-16	Medios cosmeticos desodorizantes.
DE69724243D1 (de)	2003-09-25	Blutstillender schwamm auf kollagenbasis
PT799578E (pt)	2002-11-29	Preparacao combinada contendo germes enriquecidos com electrolitos
SE9504505D0 (sv)	1995-12-15	Förvaringslösning
ATE295147T1 (de)	2005-05-15	Oxidationsfärbungszusammensetzung für keratinische fasern und färbungsverfahren mit derselben
DE59100051D1 (de)	1993-04-08	Mittel zur faerbung von haaren und anwendung desselben.
DE3780940D1 (de)	1992-09-10	Verwendung von ketonderivaten zur behandlung von depressionen.
ATA189793A (de)	2000-06-15	Lösung zur perfusion, konservierung und reperfusion von organen
DE60001555D1 (de)	2003-04-10	Wässrige lösung zum konservieren von gewebe und organen
DK0775439T3 (da)	2003-05-19	Sammensætninger indeholdende dialkyl(C1-C6)-ketonperoxid til konservering af organiske væv og påføring af sammensætningerne til konservering og anatomisk præparering af organiske væv af dyrisk eller menneskelig oprindelse
DE69803383D1 (de)	2002-02-28	Selektive inhibitoren des faktors x, eine azepinonstruktur enthaltend
TR199901386T2 (en)	1999-09-21	�midazopiridazinler.
DE59900067D1 (de)	2001-05-17	Verwendung eines Mittels zur Haarbehandlung
ES2069834T3 (es)	1995-05-16	Composiciones microbicidas que contienen 4,5-dicloro-2-ciclohexil-3-isotiazolona y 3-yodo-2-propinilbutil-carbamato.
ATE78463T1 (de)	1992-08-15	Schwefelhaltige acrylsaeureester und diese enthaltende fungizide.
EP0932337A4 (de)	1999-12-29	Vitrifizierungslösungen zur langfristigen aufbewahrung von zellen, geweben, organen und organismen
ES2190918T3 (es)	2003-09-01	Agente antiseptico/antifungico y composicion de linimento endermico que lo contiene.
EP0697169A4 (de)	1996-04-17	Organkonservierungsmittel
ATE309807T1 (de)	2005-12-15	Zusammensetzung zur behandlung von atherosklerose,welche ein statin und ex-vivo behandeltes blut enthält
DE60011107D1 (de)	2004-07-01	Sterilisationsmittel und -verfahren
ATE292970T1 (de)	2005-04-15	Topische zusammensetzung enthaltend brucin und ihre verwendung zur behandlung von hautschäden